Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (FY)Apr 30, 2022 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | -45.42%-15.28B | -59.86%-4.77B | -85.17%-10.51B | -2.98B | -5.67B |
Net profit before non-cash adjustment | 1.01%-9.22B | -3.63%-3.4B | -67.41%-9.31B | ---3.28B | ---5.56B |
Total adjustment of non-cash items | -34.81%-3.25B | -2,639.88%-2.52B | -363.59%-2.41B | ---91.9M | ---519.88M |
-Depreciation and amortization | 62.45%739.72M | 9.51%210.41M | 136.62%455.35M | --192.14M | --192.44M |
-Disposal profit | --0 | --0 | --0 | --0 | --0 |
-Net exchange gains and losses | -902.66%-2.7B | -473.65%-1.8B | 54.24%-268.89M | ---313.31M | ---587.57M |
-Remuneration paid in stock | 2,222.09%99.04M | 4,189.61%86.26M | -64.30%4.27M | --2.01M | --11.95M |
-Other non-cash items | 46.49%-1.39B | -3,832.14%-1.02B | -1,802.59%-2.6B | --27.26M | ---136.7M |
Changes in working capital | -330.60%-2.81B | 197.15%1.14B | 197.30%1.22B | --384.59M | --409.74M |
-Change in receivables | -94.29%-1.74B | -690.90%-1.56B | -252.08%-894.72M | ---197.06M | --588.33M |
-Change in payables | -15.66%881.87M | 703.73%1.93B | 131.81%1.05B | --239.64M | --451.08M |
-Provision for loans, leases and other losses | -282.96%-1.95B | 126.68%775.25M | 269.50%1.07B | --342.01M | ---629.67M |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | -111.50%-493.24M | 2.44%-126.24M | -1,720.08%-233.21M | -129.4M | -12.81M |
Interest received (cash flow from operating activities) | 780.89%67.93M | 207.36%19.21M | 3,154.01%7.71M | 6.25M | 237K |
Tax refund paid | -103.95%-1.3M | 0 | 2,420.92%32.96M | -17K | -1.42M |
Other operating cash inflow (outflow) | 4.38%2.88B | 115,517,800.00%1.16B | 1,384.58%2.76B | -1K | 185.97M |
Operating cash flow | -61.55%-12.82B | -19.81%-3.72B | -44.28%-7.94B | ---3.11B | ---5.5B |
Investing cash flow | |||||
Net PPE purchase and sale | 29.19%-1.08B | 75.19%-141.73M | -218.13%-1.53B | ---571.36M | ---480.49M |
Net intangibles purchase and sale | -718.62%-87.51M | -91,522.22%-41.14M | 57.20%-10.69M | --45K | ---24.98M |
Net changes in other investments | 86.43%-12.96M | -200.00%-1K | 39.27%-95.47M | --1K | ---157.2M |
Investing cash flow | 27.64%-1.18B | 67.99%-182.88M | -146.69%-1.63B | ---571.31M | ---662.67M |
Financing cash flow | |||||
Net issuance payments of debt | -32.30%3.4B | -1.45%1.83B | 247.78%5.02B | --1.86B | --1.44B |
Net common stock issuance | -90.22%999.7M | -99.97%3.2M | -18.01%10.22B | --10.19B | --12.47B |
Increase or decrease of lease financing | -1,795.23%-252.79M | -150.14%-62.92M | 88.38%-13.34M | --125.49M | ---114.83M |
Net other fund-raising expenses | 0.00%-1K | --0 | -200.00%-1K | --0 | --1K |
Financing cash flow | -72.77%4.15B | -85.43%1.77B | 10.39%15.23B | --12.17B | --13.79B |
Net cash flow | |||||
Beginning cash position | 34.44%22.68B | 8.53%15.25B | 88.62%16.87B | --14.05B | --8.94B |
Current changes in cash | -274.35%-9.86B | -125.11%-2.13B | -25.88%5.66B | --8.5B | --7.63B |
Effect of exchange rate changes | 790.24%1.38B | 708.88%1.08B | -47.61%154.68M | --133.62M | --295.23M |
End cash Position | -37.40%14.2B | -37.40%14.2B | 34.44%22.68B | --22.68B | --16.87B |
Free cash flow | -47.65%-13.99B | -6.17%-3.91B | -57.76%-9.48B | ---3.68B | ---6.01B |
Currency Unit | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |